The effect of timolol maleate 0.5% gel and timolol maleate 0.5% solution twice daily versus placebo on pulmonary function in older primary open-angle glaucoma or ocular hypertensive patients

被引：0
|
作者：
Lindsay, CL
Stewart, JA
Day, DG
Holmes, KT
Stewart, WC
机构：
[1] Atlanta Res Co, Atlanta, GA USA
[2] Pharmaceut Res Corp, Charleston, SC USA
[3] Univ S Carolina, Sch Med, Columbia, SC 29208 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2742B988
引用
收藏
页码：S515 / S515
页数：1
相关论文
共 50 条
  • [1] Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    Day, DG
    Schacknow, PN
    Wand, M
    Sharpe, ED
    Stewart, JA
    Leech, J
    Stewart, WC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (02) : 138 - 143
  • [2] Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma
    Harris, A
    Jonescu-Cuypers, CP
    Kagemann, L
    Nowacki, EA
    Garzozi, H
    Cole, C
    Martin, B
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) : 490 - 495
  • [3] Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma
    Konstas, AGP
    Stewart, WC
    Topouzis, F
    Tersis, I
    Holmes, KT
    Stangos, NT
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (06) : 729 - 733
  • [4] Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    Sharpe, ED
    Henry, CJ
    Mundorf, TK
    Day, DG
    Stewart, JA
    Jenkins, JN
    Stewart, WC
    EYE, 2005, 19 (01) : 35 - 40
  • [5] Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    E D Sharpe
    C J Henry
    T K Mundorf
    D G Day
    J A Stewart
    J N Jenkins
    W C Stewart
    Eye, 2005, 19 : 35 - 40
  • [6] Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma
    Schenker, H
    Maloney, S
    Liss, C
    Gormley, G
    Hartenbaum, D
    CLINICAL THERAPEUTICS, 1999, 21 (01) : 138 - 147
  • [7] The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily
    Mundorf, TK
    Cate, EA
    Sine, CS
    Otero, DW
    Stewart, JA
    Stewart, WC
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1998, 14 (02) : 129 - 135
  • [8] The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients
    Konstas, AGP
    Maltezos, A
    Mantziris, DA
    Sine, CS
    Stewart, WC
    EYE, 1999, 13 (3) : 314 - 318
  • [9] The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients
    Anastasios G P Konstas
    Anastasios Maltezos
    Dimitrios A Mantziris
    Cheryl S Sine
    William C Stewart
    Eye, 1999, 13 : 314 - 318
  • [10] Effects of Latanoprost 0.005%/ Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
    Yuce, Berna
    Yilmaz, Suzan Guven
    Andac, Kutay
    Ates, Halil
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 5 - 10
12345